RE: SBTX27 Sep 2021 14:28
Think over the weekend we got a little side tracked talking about other potential opportunities, but feel it pretty important to keep our eyes firmly on the prize, and the 5 pillars that SBTX is concentrating on.
Was great towards the end of last week to see everyone's contributions to the posts and even TT, started getting interested in royalties when I think a lot of us had to sharply upgrade our royalty expectations.
We saw just how much one 20T batch could produce, now we know Croda was investing 5M in a dedicated production line, this is because they want to churn our products out week in week out 24/7.
Indeed we know 25K subs for psoriasis will rake in circa 12M, I'd wager royalties could be higher than that once things are really rolling.
https://www.skinbiotherapeutics.com/sectors/
Certainly I believe quite a few investors read these posts and have looking at the trading action over the past few sessions have upgraded the potential here by quite a bit. All we are seeing is that reaction now.
Lastly must talk about the all important timeline, with OPTI we had good products and deals with other companies that because we were at their mercy so to speak had to suffer years before royalties started to even get warmed up which is the kiss of death to any share price. Things are completely different here.
We know that the psoriasis treatment being manufactured by Winclove will be available last quarter this year, which actually starts in a few days. Stuart never likes to let anyone down, and actually makes a very firm point about it. I believe the company has build some slippage into this timeline in view of the current worldwide issues with supply, COVID, parts, regulation and distribution. However at the last interview he affirmed that "things are firmly on track and to plan". I believe subscriptions will indeed start very soon indeed. So the all important timeline means we don't have long to wait at all.
Many traders and investors know this, and the buyers today are indicative of positions being retaken, (yep know many sold not because they didn't like the products or company, but saw a chance of buying back cheaper). This window has now closed.